|
Journal references for ZMC's HTLV p19 Antigen ELISA Kit
Delebecque F, Pramberger K, Prevost MC, et al. A Chimeric Human T-Cell Lymphotropic Virus Type 1 with the Envelope Glycoprotein of Moloney Murine Leukemia Virus Is Infectious for Murine Cells. J Virol. 2002; 76 (15): 7883-7889.
Derse D, Hill SA, Lloyd PA, et al. Examining Human T-Lymphotropic Virus Type 1 Infection and Replication by Cell-Free Infection with Recombinant Virus Vectors. J Virol. 2001; 75 (18): 8461-8468.
Dorweiler IJ, Ruone SJ, Wang H, et al. Role of the Human T-Cell Leukemia Virus Type 1 PTAP Motif in Gag Targeting and Particle Release. J Virol. 2006; 80 (7): 3634-3643.
Dumais N, Pare ME, Mercier S, et al. T-Cell Receptor/CD28 Engagement When Combined with Prostaglandin E 2 Treatment Leads to Potent Activation of Human T-Cell Leukemia Virus Type 1. J Virol. 2003; 77 (20): 11170-11179.
Hakata Y, Yamada M, Shida H. A Multifunctional Domain in Human CRM1 (Exportin 1) Mediates RanBP3 Binding and Multimerization of Human T-Cell Leukemia Virus Type 1 Rex Protein. Mol Cell Biol. 2003; 23 (23): 8751-8761.
Hiraragi H, Kim SJ, Phipps AJ, et al. Human T-Lymphotropic Virus Type 1 Mitochondrion-Localizing Protein p13 II Is Required for Viral Infectivity In Vivo. J Virol. 2006; 80 (7): 3469-3476.
Kazanji M, Tartaglia J, Franchini G, et al. Immunogenicity and Protective Efficacy of Recombinant Human T-Cell Leukemia/Lymphoma Virus Type 1 NYVAC and Naked DNA Vaccine Candidates in Squirrel Monkeys ( Saimiri sciureus ). J Virol. 2001; 75 (13): 5939-5948.
Koiwa T, Hamano-Usami A, Ishida T, et al. 5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo. J Virol. 2002; 76 (18): 9389-9397.
Kress E, Baydoun HH, Bex F, et al. Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytes. Retrovirology. 2005; 2: 8.
Sibon D, Gabet AS, Zandecki M, et al. HTLV-1 propels untransformed CD4 + lymphocytes into the cell cycle while protecting CD8 + cells from death. J Clin Invest. 2006; 116 (4): 974-983.
Silverman LR, Phipps AJ, Montgomery A, et al. Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30 II Is Required for In Vivo Replication: Evidence of In Vivo Reversion. J Virol. 2004; 78 (8): 3837-3845.
Silverman LR, Phipps AJ, Montgomery A, et al. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations. Blood. 2005; 106 (10): 3602-3608.
Sun B, Nitta T, Shoda M, et al. Cell-free Human T-cell Leukemia Virus Type 1 Binds to, and Efficiently Enters Mouse Cells. Jpn. J. Cancer Res. 2002; 93: 760-766.
Xie L and Green PL. Envelope Is a Major Viral Determinant of the Distinct In Vitro Cellular Transformation Tropism of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2. J Virol. 2005; 79 (23): 14536-14545.
Younis I, Khair L, Dundr M, et al. Repression of Human T-Cell Leukemia Virus Type 1 and Type 2 Replication by a Viral mRNA-Encoded Posttranscriptional Regulator. J Virol. 2004; 78 (20): 11077-11083.
Younis I, Yamamoto B, Phipps A, et al. Human T-Cell Leukemia Virus Type 1 Expressing Nonoverlapping Tax and Rex Genes Replicates and Immortalizes Primary Human T Lymphocytes but Fails To Replicate and Persist In Vivo. J Virol. 2005; 79 (23): 14473-14481.
|
